Strategies for Multivessel Revascularization in Patients with Diabetes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease. METHODS In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG. The patients were followed for a minimum of 2 years (median among survivors, 3.8 years). All patients were prescribed currently recommended medical therapies for the control of low-density lipoprotein cholesterol, systolic blood pressure, and glycated hemoglobin. The primary outcome measure was a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke. RESULTS From 2005 through 2010, we enrolled 1900 patients at 140 international centers. The patients' mean age was 63.1±9.1 years, 29% were women, and 83% had three-vessel disease. The primary outcome occurred more frequently in the PCI group (P=0.005), with 5-year rates of 26.6% in the PCI group and 18.7% in the CABG group. The benefit of CABG was driven by differences in rates of both myocardial infarction (P<0.001) and death from any cause (P=0.049). Stroke was more frequent in the CABG group, with 5-year rates of 2.4% in t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Impressively, these results were consistent across all prespecified subgroups.274,275,292”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“(30-day stroke rate for CABG versus PCI, 1.8% versus 0.3%274)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“as did the individual outcomes of death (16.3% versus 10.9%; P<0.05)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“the primary composite outcome of 5-year rates of death resulting from any cause, nonfatal myocardial infarction, or nonfatal stroke occurred more frequently in the PCI group (26.6% versus 18.7%; P=0.005)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“although stroke was more common after CABG (5.2% versus 2.4%; P=0.03).”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333 · cited 1×
“Of these patients, 25% have diabetes.(1,2) In the Bypass Angioplasty Revascularization Investigation (BARI) trial, patients with diabetes and multivessel disease who underwent coronaryartery bypass grafting (CABG) lived longer than did patients undergoing balloon angioplasty, a finding that led to guideline recommenda…”
BackgroundSerruys, P. W., Morice, M.-C., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., van den Brand, M., Bass, E. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804626 · Cited by 4,331 · cited 6×
“In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG.”
ResultInfluentialSelf-citationDeveloped with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Self-citationThe SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.
Sianos, G., Morel, M., Kappetein, A. P., Morice, M., Colombo, A., Dawkins, K. D., van den Brand, M., Dyck, N. V., Russell, M. E., Mohr, F. W., et al. (2005) · PubMed · Cited by 2,293
ACC/AHA guidelines for coronary artery bypass graft surgery
Eagle, K. A., Guyton, R. A., Davidoff, R., Ewy, G. A., Fonger, J., Gardner, T. J., Gott, J. P., Herrmann, H. C., Marlow, R. A., Nugent, W. C., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00389-7 · Cited by 1,995
Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350401 · Cited by 1,531
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery
Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., Hutter, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.009 · Cited by 820
Self-citationHlatky, M. A., Boothroyd, D. B., Bravata, D. M., Boersma, E., Booth, J., Brooks, M. M., Carrié, D., Clayton, T. C., Danchin, N., Flather, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60552-3 · Cited by 735 · cited 1×
“A comprehensive meta-analysis of trials performed before the introduction of drug-eluting stents showed excess mortality after PCI, as compared with CABG, in patients with diabetes.(20) Although our study was not powered to detect a difference in all-cause mortality, we observed a significantly (P = 0.”
ResultSelf-citationInvestigators, T. B. (1997) · Circulation · doi:10.1161/01.cir.96.6.1761 · Cited by 619
Research works printed but not linked: 1
- Sianos G, 2005, EuroIntervention, 1, 219
Cited by
Items 101–200 of 999
Chronic Coronary Artery Disease
Pai, R. G., Varadarajan, P., & Pai, S. M. (2018) · Cardiology board review · doi:10.1002/9781118698983.ch10 · Cited by 136
Roffi, M., Patrono, C., Collet, J., Mueller, C. E., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2015.10.009 · Cited by 150
Stefanini, G. G., Baber, U., Windecker, S., Morice, M., Sartori, S., Leon, M. B., Stone, G. W., Serruys, P. W. J. C., Wijns, W. C., Weisz, G., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61782-1 · Cited by 135
2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation
Барбараш, О. Л., Duplyakov, D. V., Zateischikov, D. A., Панченко, Е. П., Shakhnovich, R. M., Yavelov, I. S., Yakovlev, A. N., Sa, A., Alekyan, B. G., Викторович, А. М., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4449 · Cited by 149
Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease
Puskas, J. D., Halkos, M. E., DeRose, J. J., Bagiella, E., Miller, M. A., Overbey, J., Bonatti, J. O., Srinivas, V. S., Vesely, M. R., Sutter, F. P., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.032 · Cited by 134
Results of the minimally invasive coronary artery bypass grafting angiographic patency study
Ruel, M., Shariff, M. A., Lapierre, H. R., Goyal, N., Dennie, C. J., Sadel, S. M., Sohmer, B., & McGinn, J. T. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.09.016 · Cited by 134
Magnuson, E. A., Farkouh, M. E., Fuster, V., Wang, K., Vilain, K., Li, H., Appelwick, J., Muratov, V., Sleeper, L. A., Boineau, R., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.147488 · Cited by 131
Self-citationFihn, S. D., Blankenship, J. C., Alexander, K. P., Bittl, J. A., Byrne, J. G., Fletcher, B. J., Fonarow, G. C., Lange, R. A., Levine, G. N., Maddox, T. M., et al. (2015) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.11.002 · Cited by 131
Coronary artery bypass grafting: Part 2--optimizing outcomes and future prospects
Head, S. J., Börgermann, J., Osnabrugge, R. L. J., Kieser, T. M., Falk, V., Taggart, D. P., Puskas, J. D., Gummert, J. F., & Kappetein, A. P. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht284 · Cited by 146
Comprehensive Cardiovascular Risk Factor Control Improves Survival
Bittner, V., Bertolet, M., Barraza Felix, R., Farkouh, M. E., Goldberg, S., Ramanathan, K. B., Redmon, J. B., Sperling, L., & Rutter, M. K. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.019 · Cited by 127
Self-citationCauses of Death Following PCI Versus CABG in Complex CAD
Milojevic, M., Head, S. J., Parasca, C. A., Serruys, P. W. J. C., Mohr, F. W., Morice, M., Mack, M. J., Ståhle, E., Feldman, T. E., Dawkins, K. D., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.043 · Cited by 131
“These concepts were validated in several studies that demonstrated that CABG had more durable protection against MI in patients with extensive CAD (16,27,28).”
ResultInfluentialSelf-citationReperfusion Strategies in Acute Coronary Syndromes
Bagai, A., Dangas, G., Stone, G. W., & Granger, C. B. (2014) · Circulation Research · doi:10.1161/circresaha.114.302744 · Cited by 148
Self-citationVerma, S., Mazer, C. D., Fitchett, D., Inzucchi, S. E., Pfarr, E., George, J. T., & Zinman, B. (2018) · Diabetologia · doi:10.1007/s00125-018-4644-9 · Cited by 124
“The 5 year event rate of major adverse cardiovascular events (MACE) after CABG in participants with diabetes was 19% in the FREEDOM trial and 29% in the SYNTAX trial [4, 5].”
BackgroundGiacoppo, D., Colleran, R., Cassese, S., Frangieh, A. H., Wiebe, J., Joner, M., Schunkert, H., Kastrati, A., & Byrne, R. A. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.2895 · Cited by 124
Gregson, J., Stone, G. W., Ben‐Yehuda, O., Redfors, B., Kandzari, D. E., Morice, M., Leon, M. B., Kosmidou, I., Lembo, N., Brown, W. M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.016 · Cited by 123
Gaudino, M., Hameed, I., Farkouh, M., Rahouma, M., Naik, A., Robinson, N., Ruan, Y., Demetres, M., Biondi-Zoccai, G., Angiolillo, D., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.4748 · Cited by 88
Self-citationHabib, R., Dimitrova, K. R., Badour, S. A., Yammine, M. B., Sleiman, K., Hoffman, D. M., Geller, C. M., Schwann, T. A., & Tranbaugh, R. F. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.060 · Cited by 122
Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes
Kaul, U., Bangalore, S., Seth, A., Arambam, P., Abhaichand, R. K., Patel, T. M., Banker, D. N., Abhyankar, A. D., Mullasari, A., Shah, S. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510188 · Cited by 125
Early Versus Delayed Stroke After Cardiac Surgery: A Systematic Review and Meta‐Analysis
Gaudino, M. F. L., Rahouma, M., Mauro, M. D., Yanagawa, B., Abouarab, A., Demetres, M. R., Franco, A. D., Arisha, M. J., Ibrahim, D. A., Baudo, M., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012447 · Cited by 128
Koskinas, K. C., Siontis, G. C. M., Piccolo, R., Franzone, A., Haynes, A., Rat-Wirtzler, J., Silber, S., Serruys, P. W., Pilgrim, T., Räber, L., et al. (2016) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.115.003255 · Cited by 119
Compliance With Guideline-Directed Medical Therapy in Contemporary Coronary Revascularization Trials
Pinho‐Gomes, A., Azevedo, L. F., Ahn, J., Park, S., Hamza, T. H., Farkouh, M. E., Serruys, P. W. J. C., Milojevic, M., Kappetein, A. P., Stone, G. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.068 · Cited by 131
“BEST ¼ Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients with Multivessel Coronary Artery Disease trial; EXCEL ¼ Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization trial; FREEDOM ¼ Futu…”
BackgroundMethodInfluentialSelf-citationRamanathan, K., Abel, J. G., Park, J. E., Fung, A., Mathew, V., Taylor, C. M., Mancini, G. B. J., Gao, M., Ding, L., Verma, S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.029 · Cited by 128
“Both the observational and the randomized cohorts were similar in incidence of hypertension and in percentage of female sex (3).”
BackgroundResultSelf-citationManagement of Left Main Coronary Artery Disease
Ramadan, R., Boden, W. E., & Kinlay, S. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008151 · Cited by 129
“Thus, it remains unproven whether optimal medical therapy may be a safe and appropriate therapeutic alternative to revascularization in certain, select subsets of lower-risk patients with stable LM CAD.”
BackgroundInfluentialThe SYNTAX score and its clinical implications
Head, S. J., Farooq, V., Serruys, P. W. J. C., & Kappetein, A. P. (2013) · Heart · doi:10.1136/heartjnl-2012-302482 · Cited by 116
BANNING, A. P., Serruys, P. W. J. C., Maria, G. L. D., Ryan, N., Walsh, S. J., Gonzalo, N., van Geuns, R., Onuma, Y., Sabaté, M., Davies, J. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab703 · Cited by 129
Raza, S., Sabik, J. F., Masabni, K., Ainkaran, P., Lytle, B. W., & Blackstone, E. H. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.06.058 · Cited by 114
“The surgical revascularization techniques investigated included (1) SITA (n 1⁄4 8466; 71%) and BITA (n 1⁄4 938; 7.”
BackgroundMethodInfluentialPanza, J. A., Velazquez, E. J., She, L., Smith, P. K., Nicolau, J. C., Favaloro, R. R., Gradinac, S., Chrzanowski, L., Prabhakaran, D., Howlett, J. G., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.064 · Cited by 134
Ahn, J., Park, D., Lee, C. W., Chang, M., Cavalcante, R., Sotomi, Y., Onuma, Y., Tenekecioğlu, E., Han, M., Lee, P. H., et al. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.04.037 · Cited by 112
“Based on results from clinical trials, clinical guidelines favor CABG as the primary revascularization strategy in these groups (1,2,4).”
BackgroundEvaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm
Ferraro, R., Latina, J. M., Alfaddagh, A., Michos, E. D., Blaha, M. J., Jones, S. R., Sharma, G. V., Trost, J. C., Boden, W. E., Weintraub, W. S., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.078 · Cited by 131
Self-citationTian, M., Wang, X.-Q., Sun, H., Feng, W., Song, Y., Lü, F., Wang, L., Wang, Y., Xu, B., Wang, H., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.055525 · Cited by 122
Left Main Coronary Artery Stenosis
Athappan, G., Patvardhan, E. A., Tuzcu, M., Ellis, S. G., Whitlow, P. L., & Kapadia, S. R. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.07.008 · Cited by 119
Campos, C. M., Klaveren, D. V., Farooq, V., Simonton, C. A., Kappetein, A. P., Sabik, J. F., Steyerberg, E. W., Stone, G. W., Serruys, P. W. J. C., & the EXCEL Trial Investigators (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu518 · Cited by 108
“8 years.(27) Importantly, ULMCA disease was an exclusion criteria in FREEDOM and is what prompted the presentation of mortality predictions in the diabetic subset of EXCEL.”
BackgroundRiley, R. F., Henry, T. D., Mahmud, E., Kirtane, A. J., Brilakis, E. S., Goyal, A., Grines, C. L., Lombardi, W. L., Maran, A., Rab, T., et al. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28994 · Cited by 131
“CABG is the guideline-recommended choice of revascularization in patients with diabetes mellitus presenting with multivessel or LM CAD and average surgical risk.(8,31,69,70) However, some patients may”
BackgroundAnti-atherosclerotic therapies: Milestones, challenges, and emerging innovations
Hetherington, I., & Totary-Jain, H. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.08.024 · Cited by 126
“Several randomized trials have shown that in patients with severe coronary artery disease (CAD) and DM, CABG was superior to PCI.(77,78) PCI originally started with simple balloon angioplasty to open up occluded vessels and restore blood flow.”
BackgroundInfluentialHandberg, E. M., Merz, C. N. B., Cooper‐DeHoff, R. M., Wei, J., Conlon, M., Lo, M. C., Boden, W. E., Frayne, S. M., Villines, T. C., Spertus, J. A., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.03.011 · Cited by 119
Kowaltowski, A. J., & Abdulkader, F. (2020) · Springer eBooks · doi:10.1007/978-3-030-50968-2_9 · Cited by 106
Nagendran, J., Bozso, S. J., Norris, C. M., McAlister, F. A., Appoo, J. J., Moon, M. C., Freed, D. H., & Nagendran, J. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.024 · Cited by 105
“Prior reports have suggested an increased risk for stroke in patients with DM treated with CABG (4).”
BackgroundNeurological complications of cardiac surgery
McDonagh, D. L., Berger, M., Mathew, J. P., Graffagnino, C., Milano, C. A., & Newman, M. F. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70004-3 · Cited by 111
Cornwell, L. D., Omer, S., Rosengart, T. K., Holman, W. L., & Bakaeen, F. G. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2014.1700 · Cited by 124
2013 ESC GUIDELINES ON THE MANAGEMENT OF STABLE CORONARY ARTERY DISEASE
Montalescot, G., Sechtem, U. P., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., Mario, C. D., et al. (2014) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2014-7-7-79 · Cited by 109
Self-citationCavalcante, R., Sotomi, Y., Mancone, M., Lee, C. W., Ahn, J., Onuma, Y., Lemos, P. A., van Geuns, R., Park, S., & Serruys, P. W. J. C. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx138 · Cited by 106
Early clinical and angiographic outcomes after robotic-assisted coronary artery bypass surgery
Halkos, M. E., Liberman, H. A., Devireddy, C. M., Walker, P. F., Finn, A. V., Jaber, W. A., Guyton, R. A., & Puskas, J. D. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.09.010 · Cited by 101
“Coronary artery bypass grafting (CABG) is an established method of treating patients with coronary artery disease, with recent trials reemphasizing its efficacy and durability.(1,2) An important component of the benefit conferred by CABG is derived from the left internal thoracic artery (LITA) graft to the left anteri…”
BackgroundMethodKedhi, E., Généreux, P., Palmerini, T., McAndrew, T., Parise, H., Mehran, R., Dangas, G., & Stone, G. W. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.064 · Cited by 113
Self-citationPrognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure
Johansson, I., Dahlström, U., Edner, M., Näsman, P., Rydén, L., & Norhammar, A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.061 · Cited by 105
“50 Valvular heart disease 1,041 (18) 429 (16) 0.”
MethodInfluentialWindecker, S., Neumann, F., Jüni, P., Sousa‐Uva, M., & Falk, V. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy532 · Cited by 106
Evidence in Guidelines for Treatment of Coronary Artery Disease
Jia, S., Liu, Y., & Yuan, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2517-9_2 · Cited by 123
Bittl, J. A., & He, Y. (2017) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.117.003563 · Cited by 111
State of the art: coronary artery stents – past, present and future
Stefanini, G. G., Byrne, R. A., Windecker, S., & Kastrati, A. (2017) · EuroIntervention · doi:10.4244/eij-d-17-00557 · Cited by 96
Coronary Artery Revascularization in Patients With Diabetes Mellitus
Armstrong, E. J., Rutledge, J. C., & Rogers, J. H. (2013) · Circulation · doi:10.1161/circulationaha.113.002114 · Cited by 108
Cohen, D. J., Osnabrugge, R. L. J., Magnuson, E. A., Wang, K., Li, H., Chinnakondepalli, K., Pinto, D. S., Abdallah, M., Vilain, K. R., Morice, M., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.009985 · Cited by 96
Self-citationHakeem, A., Garg, N., Bhatti, S., Rajpurohit, N., Ahmed, Z., & Uretsky, B. F. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000354 · Cited by 96
Babeş, E. E., Bustea, C., Behl, T., Abdel‐Daim, M. M., Nechifor, A. C., Stoicescu, M., Brisc, M. C., Moisi, M. I., Gîtea, D., Iovanovici, D. C., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112772 · Cited by 110
Liang, Z., Wu, G., Fan, C., Xu, J., Jiang, S., Yan, X., Di, S., Ma, Z., Hu, W., & Yang, Y. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.11.001 · Cited by 95
Silber, S., Serruys, P. W. J. C., Leon, M. B., Meredith, I. T., Windecker, S., Neumann, F., Belardi, J., Widimský, P., Massaro, J., Novack, V., et al. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.11.006 · Cited by 91
Minimally invasive and robotic coronary artery bypass grafting—a 25-year review
Bonatti, J. O., Wallner, S., Crailsheim, I., Grabenwöger, M., & Winkler, B. M. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-20-1535 · Cited by 90
Guideline For Stable Coronary Artery Disease
César, L. A. M., Ferreira, J., Armaganijan, D., Gowdak, L. H. W., Mansur, A. D. P., Bodanese, L., Sposito, A. C., Sousa, A. C., Aj, C., Markman, B., et al. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.2014s004 · Cited by 124
Yanagawa, B., Verma, S., Mazine, A., Tam, D. Y., Jüni, P., Puskas, J. D., Murugavel, S., & Friedrich, J. O. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.02.010 · Cited by 88
The Relationships Between Cardiovascular Disease and Diabetes
Kovacic, J. C., Castellano, J. M., Farkouh, M. E., & Fuster, V. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.007 · Cited by 101
“With longterm follow-up out to 5 years, the SYNTAX study showed a clear advantage of CABG over PCI for left main and triple vessel disease.71 C a rd io va scu la r D ise a se a n d D ia b e te s 5 1 The FREEDOM Trial, published in theNew England Journal of Medicine in December 2012, provided a comprehensive insight in…”
MethodSelf-citationTam, D. Y., Dharma, C., Rocha, R., Farkouh, M. E., Abdel-Qadir, H., Sun, L. Y., Wijeysundera, H. C., Austin, P. C., Udell, J. A., Gaudino, M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.06.052 · Cited by 86
“The Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Diseases (FREEDOM) trial was designed to compare PCI performed using drug eluting stents (DES) to CABG in diabetic patients with multi-vessel disease.(5) The trial randomized 1900 diabetic patients to interven…”
MethodSelf-citationCoronary artery bypass grafting in diabetics: A growing health care cost crisis
Raza, S., Sabik, J. F., Ainkaran, P., & Blackstone, E. H. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.03.041 · Cited by 94
“However, the increasing use of percutaneous coronary intervention for revascularization, and the choice of CABG as the preferred revascularization strategy for diabetics, could also have been contributing factors.(16) Although cardiovascular”
BackgroundSYNTAX Score and Long-Term Outcomes
Ikeno, F., Brooks, M. M., Nakagawa, K., Kim, M.-K., Kaneda, H., Mitsutake, Y., Vlachos, H. A., Schwartz, L., Frye, R. L., Kelsey, S. F., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.067 · Cited by 85
Self-citationChang, M., Lee, C. W., Ahn, J., Cavalcante, R., Sotomi, Y., Onuma, Y., Han, M., Park, D., Kang, S., Lee, S., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.04.038 · Cited by 92
Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes
Milojevic, M., Serruys, P. W. J. C., Sabik, J. F., Kandzari, D. E., Schampaert, É., Boven, A. J. V., Horkay, F., Ungi, I., Mansour, S., BANNING, A. P., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.037 · Cited by 86
“In this regard, a large propensity-matched analysis of 4,048 patient-pairs from the New York State outcomes registries suggested that the apparent survival benefit of CABG over PCI in diabetic patients in the FREEDOM (Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes) an…”
BackgroundResultBangalore, S., Guo, Y., Samadashvili, Z., Blecker, S., Xu, J., & Hannan, E. L. (2015) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.115.002626 · Cited by 83
Widening clinical applications of the SYNTAX Score
Farooq, V., Head, S. J., Kappetein, A. P., & Serruys, P. W. J. C. (2013) · Heart · doi:10.1136/heartjnl-2013-304273 · Cited by 96
Wu, I.-C., Lin, C.-C., & Hsiung, C. A. (2015) · BioMedicine · doi:10.7603/s40681-015-0001-1 · Cited by 81
“Furthermore, the benefits and harms of treatment of one disease could considerably vary among older patients with different profiles of comorbid conditions [12, 39-41].”
BackgroundBen‐Yehuda, O., Chen, S., Redfors, B., McAndrew, T., Crowley, A., Kosmidou, I., Kandzari, D. E., Puskas, J. D., Morice, M., Taggart, D. P., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz113 · Cited by 81
Zimmermann, F. M., Bruyne, B. D., Pijls, N. H. J., Desai, M., Oldroyd, K. G., Park, S., Reardon, M. J., Wendler, O., Woo, Y.-P. J., Yeung, A. C., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.06.024 · Cited by 80
“This difference was driven by higher rates of death and MI in the PCI arm with higher rates of CVA in the CABG arm.(8) Based on these 2 studies, most patients with 3-VD are now routinely referred for CABG, particularly if they have an intermediate or high SYNTAX score.”
BackgroundMaking Sense of Statistics in Clinical Trial Reports
Pocock, S., McMurray, J. J. V., & Collier, T. J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.014 · Cited by 86
“For instance, the FREEDOM trial (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) (13) of coronary artery bypass grafting (CABG) versus PCI has a primary”
MethodCho, M. S., Ahn, J., Lee, C.-H., Kang, D., Lee, J.-B., Lee, P. H., Kang, S., Lee, S., Kim, Y., Lee, C. W., et al. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.05.051 · Cited by 79
Hlatky, M. A., Boothroyd, D. B., Baker, L. C., Kazi, D. S., Solomon, M. D., Chang, T. I., Shilane, D. A., & Go, A. S. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-10-201305210-00639 · Cited by 86
Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How
Liga, R., Colli, A., Taggart, D. P., Boden, W. E., & Caterina, R. D. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.026943 · Cited by 92
Naito, R., & Kasai, T. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i3.119 · Cited by 92
Bangalore, S., Toklu, B., & Feit, F. (2014) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.001346 · Cited by 77
Sex Differences in the Coronary System
Taqueti, V. R. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77932-4_17 · Cited by 83
Kogan, A., Ram, E., Levin, S., Fisman, E. Z., Tenenbaum, A., Raanani, E., & Sternik, L. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0796-7 · Cited by 78
Lindman, B. R., Pibarot, P., Arnold, S. V., Suri, R. M., McAndrew, T. C., Maniar, H. S., Zajarias, A., Kodali, S., Kirtane, A. J., Thourani, V. H., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.057 · Cited by 75
Self-citationZimarino, M., Ricci, F., Romanello, M., Nicola, M. D., Corazzini, A., & Caterina, R. D. (2015) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25923 · Cited by 75
“In “elective” myocardial revascularization, CABG seems to confer a small long-term clinical benefit over PCI, mostly evident in diabetic patients [4,5] and in patients with more extensive MVCAD [6].”
BackgroundYoung, M. N., Kolte, D., Cadigan, M. E., Laikhter, E., Sinclair, K., Pomerantsev, E., Fifer, M., Sundt, T., Yeh, R., & Jaffer, F. (2020) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.119.014738 · Cited by 67
Sequential proteome alterations during genesis and progression of colon cancer
Gustafsson, M., Bruch, H.-P., Franz�n, B., Ried, T., Bergmann, T., Auer, G., J�rnvall, H., Roblick, U. J., Hirschberg, D., Habermann, J. K., et al. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4049-4 · Cited by 81
Romaguera, R., Lara, J. G., Brugaletta, S., Pinar, E., Jiménez‐Quevedo, P., Gracida, M., Roura, G., Ferreiro, J. L., Teruel, L., Montanya, E., et al. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2015.09.020 · Cited by 74
Campos, C. M., Klaveren, D. V., Iqbal, J., Onuma, Y., Zhang, Y., García‐García, H. M., Morel, M., Farooq, V., Shiomi, H., Furukawa, Y., et al. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0204 · Cited by 81
Cardiovascular Disease in Diabetes Mellitus
Szuszkiewicz-Garcia, M., & Davidson, J. A. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.001 · Cited by 93
“4%.(88) Similar results were found in the past in a metaanalysis study.”
JCS/JSCVS 2018 Guideline on Revascularization of Stable Coronary Artery Disease
Nakamura, M., Yaku, H., Ako, J., Arai, H., Asai, T., Chikamori, T., Daida, H., Doi, K., Fukui, T., Ito, T., et al. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.1253/circj.cj-20-1282 · Cited by 70
Völz, S., Redfors, B., Angerås, O., Ioanes, D., Odenstedt, J., Koul, S. M., Valeljung, I., Dworeck, C., Hofmann, R., Hansson, E. C., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab273 · Cited by 79
Puskas, J. D., Martin, J. E., Cheng, D., Benussi, S., Bonatti, J. O., Diegeler, A., Ferdinand, F. D., Kieser, T. M., Lamy, A. L., Mack, M. J., et al. (2015) · Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery · doi:10.1097/imi.0000000000000184 · Cited by 72
Self-citationBaber, U., Farkouh, M. E., Arbel, Y., Muntner, P., Dangas, G., Mack, M. J., Hamza, T. H., Mehran, R., & Fuster, V. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw378 · Cited by 76
Self-citationNerlekar, N., Ha, F. J., Verma, K. P., Bennett, M. R., Cameron, J. D., Meredith, I. T., & Brown, A. J. (2016) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.116.004729 · Cited by 72
Myocardial Revascularization Trials
Ruel, M., Falk, V., Farkouh, M. E., Freemantle, N., Gaudino, M. F. L., Glineur, D., Cameron, D. E., & Taggart, D. P. (2018) · Circulation · doi:10.1161/circulationaha.118.035970 · Cited by 70
Self-citationPandey, A., McGuire, D. K., de Lemos, J. A., Das, S. R., Berry, J. D., Brilakis, E. S., Banerjee, S., Marso, S. P., Barsness, G. W., Simon, D. N., et al. (2016) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002084 · Cited by 75
Deb, S., Singh, S. K., Moussa, F., Tsubota, H., Une, D., Kiss, A., TOMLINSON, G. A., Afshar, M. S., Sless, R. T., Cohen, E. A., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.06.057 · Cited by 68
“The Journal of Thoracic and Car attention favoring CABG over PCI, especially in diabetic patients with advanced coronary disease.(3,4,14,15) The long-term success of CABG is dependent on graft patency and appropriate conduit choice.”
BackgroundCoronary Artery Disease and Diabetes Mellitus
Aronson, D., & Edelman, E. R. (2015) · Heart Failure Clinics · doi:10.1016/j.hfc.2015.08.010 · Cited by 74
Management of Patients With NSTE-ACS
Rodríguez, F., & Mahaffey, K. W. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.599 · Cited by 80
Empagliflozin restores the integrity of the endothelial glycocalyx in vitro
Cooper, S., Teoh, H., Campeau, M.-A., Verma, S., & Leask, R. L. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03555-2 · Cited by 72
Influence of Diabetes on Long-Term Coronary Artery Bypass Graft Patency
Raza, S., Blackstone, E. H., Houghtaling, P. L., Rajeswaran, J., Riaz, H., Bakaeen, F. G., Lincoff, A. M., & Sabik, J. F. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.061 · Cited by 73
“T he FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial demonstrated fewer deaths and myocardial infarctions in patients with diabetes and multivessel coronary artery disease after coronary artery bypass grafting (CABG) than after percutane…”
BackgroundBahrmann, A., Bahrmann, P., Baumann, J., Bauer, J. M., Brückel, E., Dreyer, M., Freitag, M., Friedl, A., Gölz, S., Grundke, S., et al. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/a-0666-0820 · Cited by 71
Ritsinger, V., Saleh, N., Lagerqvist, B., & Norhammar, A. (2015) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.002328 · Cited by 75
Strategies for Multivessel Revascularization in Patients with Diabetes: The Freedom Trial
Farmer, J. A. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0426-0 · Cited by 66
PCI or CABG for left main coronary artery disease: the SWEDEHEART registry
Persson, J., Yan, J., Angerås, O., Venetsanos, D., Jeppsson, A., Sjögren, I., Linder, R. B. A., Erlinge, D., Ivert, T., & Ömerovic, E. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad369 · Cited by 80
“There was a significant quantitative interaction for diabetes with a large difference in aHR for mortality favouring CABG over PCI.”
ResultInfluentialLima, E. G., Hueb, W. A., Garcia, R. M. R., Pereira, A. C., Soares, P. R., Favarato, D., Garzillo, C. L., Vieira, R. D., Rezende, P. C., Takiuti, M. E., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.04.017 · Cited by 65
Self-citation
Metadata
- Authors
- Farkouh, M. E., Domanski, M., Sleeper, L. A., Siami, F. S., Dangas, G., Mack, M., Yang, M., Cohen, D. J., Rosenberg, Y., Solomon, S. D., Desai, A. S., Gersh, B. J., Magnuson, E. A., Lansky, A., Boineau, R., Weinberger, J., Ramanathan, K., Sousa, J. E., Rankin, J., Bhargava, B., Buse, J., Hueb, W., Smith, C. R., Muratov, V., Bansilal, S., King, S., Bertrand, M., & Fuster, V.
- Affiliations
- University of Toronto (CA)
- Icahn School of Medicine at Mount Sinai (US)
- New England Research Institutes (US)
- Cardiovascular Research Foundation (US)
- Baylor University Medical Center (US)
- University of Missouri–Kansas City (US)
- National Heart, Lung, and Blood Institute (US)
- Brigham and Women's Hospital (US)
- Mayo Clinic (US)
- Yale University (US)
- University of British Columbia (CA)
- Instituto Dante Pazzanese de Cardiologia (BR)
- Royal Perth Hospital (AU)
- All India Institute of Medical Sciences (IN)
- University of North Carolina at Chapel Hill (US)
- Universidade de São Paulo (BR)
- NewYork–Presbyterian Hospital (US)
- Université de Lille (FR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-12-20
- Volume
- 367
- Issue
- 25
- Pages
- 2375-2384
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1946152282
- Cited by
- 1,922
- References
- 28
- Citations by year
- 2026: 75 · 2025: 85 · 2024: 75 · 2023: 97 · 2022: 132 · 2021: 127 · 2020: 130 · 2019: 120 · 2018: 135 · 2017: 150 · 2016: 182 · 2015: 201 · 2014: 207 · 2013: 181 · 2012: 17
- FWCI
- 196.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Edwards Lifesciences
- Boston Scientific Corporation
- Insulet Corporation
- Halozyme
- Medicines Company
- Novo Nordisk
- Genentech
- St. Jude Medical
- Abbott Vascular
- National Heart, Lung, and Blood Institute (U01 01HL071988, R01HL092989, U01HL071988, U01 01HL092989, 01HL092989, 01HL071988)
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Keywords
- multivessel coronary artery disease, diabetes mellitus, coronary artery bypass grafting, percutaneous coronary intervention, drug-eluting stents, revascularization strategy, myocardial infarction, stroke, all-cause mortality, FREEDOM trial
- MeSH terms
- Aged, Coronary Artery Bypass, Cardiovascular Diseases, Coronary Artery Disease, Female, Humans, Male, Middle Aged, Myocardial Infarction, Angioplasty, Balloon, Coronary, Stroke, Diabetes Complications, Kaplan-Meier Estimate, Drug-Eluting Stents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.